ECM
FLGT icon

Everence Capital Management’s Fulgent Genetics FLGT Stock Holding History

Everence Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,970
Closed -$237K – 758
2023
Q2 		$237K Buy
+5,970
New +$208K 0.02% 597
2022
Q1 		– Sell
-2,920
Closed -$294K – 752
2021
Q4 		$294K Hold
2,920
– – 0.02% 591
2021
Q3 		$263K Hold
2,920
– – 0.02% 599
2021
Q2 		$269K Hold
2,920
– – 0.02% 594
2021
Q1 		$282K Sell
2,920
-1,230
-30% -$127K 0.03% 582
2020
Q4 		$216K Buy
+4,150
New +$173K 0.02% 626

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Everence Capital Management's FLGT Position: Q3 2023 in Review

Everence Capital Management sold out of Fulgent Genetics (FLGT) in Q3 2023, closing a stake of 5,970 shares — an estimated $237K sold.

Everence Capital Management first reported a position in FLGT in Q4 2020 and held it in 6 quarters. The position peaked at $294K in Q4 2021. 201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

  • Everence Capital Management reported no remaining Fulgent Genetics position as of Q3 2023 after selling out during the quarter.
  • Everence Capital Management sold 5,970 Fulgent Genetics shares in Q3 2023, an estimated $237K.
  • Everence Capital Management first reported a position in Fulgent Genetics in Q4 2020 and held it in 6 quarters.
  • Everence Capital Management's Fulgent Genetics position peaked at $294K in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on Everence Capital Management's 13F filing for Q3 2023, filed 16 Oct 2023.